Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

148,740 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Physician-patient communication at prescription of an additional oral drug for type 2 diabetes and its links to patient outcomes - New findings from the global IntroDia® study.
Edelman S, Belton A, Down S, Alzaid A, Capehorn M, Gamerman V, Nagel F, Lee J, Emmerson J, Polonsky WH. Edelman S, et al. Among authors: lee j. Diabetes Res Clin Pract. 2019 Mar;149:89-97. doi: 10.1016/j.diabres.2019.01.020. Epub 2019 Jan 24. Diabetes Res Clin Pract. 2019. PMID: 30685350
Open letter to the William Pickles lecturer.
Belton A, Lee J. Belton A, et al. Among authors: lee j. J R Coll Gen Pract. 1984 Oct;34(267):551-4. J R Coll Gen Pract. 1984. PMID: 6492029 Free PMC article. No abstract available.
Empagliflozin as add-on to linagliptin in a fixed-dose combination in Japanese patients with type 2 diabetes: Glycaemic efficacy and safety profile in a 52-week, randomized, placebo-controlled trial.
Kawamori R, Haneda M, Suzaki K, Cheng G, Shiki K, Miyamoto Y, Solimando F, Lee C, Lee J, George J. Kawamori R, et al. Among authors: lee j, lee c. Diabetes Obes Metab. 2018 Sep;20(9):2200-2209. doi: 10.1111/dom.13352. Epub 2018 Jun 1. Diabetes Obes Metab. 2018. PMID: 29766636 Free PMC article. Clinical Trial.
Linagliptin as add-on to empagliflozin in a fixed-dose combination in Japanese patients with type 2 diabetes: Glycaemic efficacy and safety profile in a two-part, randomized, placebo-controlled trial.
Kaku K, Haneda M, Tanaka Y, Lee G, Shiki K, Miyamoto Y, Solimando F, Lee J, Lee C, George J. Kaku K, et al. Among authors: lee g, lee j, lee c. Diabetes Obes Metab. 2019 Jan;21(1):136-145. doi: 10.1111/dom.13496. Epub 2018 Sep 6. Diabetes Obes Metab. 2019. PMID: 30091172 Free PMC article. Clinical Trial.
148,740 results
You have reached the last available page of results. Please see the User Guide for more information.